[1] Mahley RW.Apolipoprotein E: cholesterol transport protein with expanding role in cell biology[J]. Science, 1988, 240(4852):622-630. [2] Minihane AM, Jofre-Monseny L, Olano-Martin E, et al.ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation[J]. Proc Nutr Soc, 2007, 66(2):183-197. [3] Mauch DH, Nagler K, Schumacher S, et al.CNS synaptogenesis promoted by glia-derived cholesterol[J]. Science, 2001, 294(5545):1354-1357. [4] Han X.The role of apolipoprotein E in lipid metabolism in the central nervous system[J]. Cell Mol Life Sci, 2004, 61(15): 1896-1906. [5] Paik YK, Chang DJ, Reardon CA, et al.Nucleotide sequence and structure of the human apolipoprotein E gene[J]. Proc Natl Acad Sci U S A, 1985, 82(10):3445-3449. [6] Khan TA, Shah T, Prieto D, et al.Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals[J]. Int J Epidemiol, 2013, 42(2):475-492. [7] Hatters DM, Peters-Libeu CA, Weisgraber KH.Apolipoprotein E structure: insights into function[J]. Trends Biochem Sci, 2006. 31(8):445-454. [8] Lahiri DK.Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene[J]. J Mol Neurosci, 2004, 23(3):225-233. [9] Dyer CA, Cistola DP, Parry GC, et al.Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor[J]. J Lipid Res, 1995, 36(1):80-88. [10] Saunders AM.Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses[J]. J Neuropathol Exp Neurol, 2000, 59(9):751-758. [11] Grainger DJ, Reckless J, McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice[J]. J Immunol, 2004, 173(10):6366-6375. [12] Brouwer DA, van Doormaal JJ, Muskiet FA. Clinical chemistry of common apolipoprotein E isoforms[J]. J Chromatogr B Biomed Appl, 1996, 678(1):23-41. [13] O’Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage[J]. N Engl J Med, 2000, 342(4):240-245. [14] Wang H, Yang H, Shivalila CS, et al.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering[J]. Cell, 2013, 153(4): 910-918. [15] Levin-Allerhand JA, Lominska CE, Smith JD.Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet[J]. J Nutr Health Aging, 2002, 6(5):315-319. [16] Strittmatter WJ, Saunders AM, Schmechel D, et al.Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease[J]. Proc Natl Acad Sci U S A, 1993, 90(5): 1977-1981. [17] Rebeck GW, Alonzo NC, Berezovska O, et al.Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes[J]. Exp Neurol, 1998, 149(1):175-182. [18] Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database[J]. Nat Genet, 2007, 39(1):17-23. [19] Sheehan D, Bennett T, Cashman K.Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk[J]. Ir J Med Sci, 2000, 169(1):50-54. [20] 唐春萍, 江涛, 郭姣. 复方贞术调脂胶囊对兔动脉粥样硬化模型脂质代谢的影响[J]. 中药材, 2010, 33(8):1285-1289. [21] 荆文, 尹苗, 杜会芹. ApoE基因缺失幼龄小鼠动脉粥样硬化相关基因的时序表达研究[J]. 生物化学与生物物理进展, 2008, 35(2):217-223. [22] 李朝辉, 王丽, 唐兰. 兔主动脉粥样硬化斑块组织中ApoE的表达[J]. 郑州大学学报: 医学版, 2006, 41(2):339-341. [23] Lamendola C.Hypertriglyceridemia and low high-density lipoprotein: risks for coronary artery disease[J]. J Cardiovasc Nurs, 2000, 14(2): 79-90. [24] 徐成斌. 血脂异常药物治疗新进展[J]. 中华心血管病杂志, 2001, 29(3):189-192. [25] Bennet AM, Di Angelantonio E, Ye Z, et al.Association of apolipoprotein E genotypes with lipid levels and coronary risk[J]. JAMA, 2007, 298(11): 1300-1311. [26] Dallongeville J, Lussier-Cacan S, Davignon J.Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis[J]. J Lipid Res, 1992, 33(4):447-454. [27] Chowdhury AH, Yokoyama T, Kokubo Y, et al.Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study[J]. J Epidemiol, 2001, 11(3):131-138. [28] 王景华, 宁宪嘉. 脑梗死患者载脂蛋白E基因多态性特点研究[J]. 中国综合临床, 2006, 22(2):118-120. [29] Sheng H, Laskowitz DT, Bennett E, et al.Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice[J]. J Cereb Blood Flow Metab, 1998, 18(4):361-366. [30] Simonet WS, Bucay N, Lauer SJ, et al.In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice[J]. J Biol Chem, 1990, 265(19):10809-10812. [31] 薛越强, 屠亚军, 琦祖和. apoE4近交系转基因鼠的高脂血症表现和自发变换行为损害[J]. 中国生物化学与分子生物学报, 2002, 18(6):772-775. [32] 周厚清, 薛越强, 琦祖和. cDNA 微阵列分析人 apoE4转基因鼠肾脏基因表达谱的变化[J]. 中国实验动物学报, 2005, 13(3):180-183. [33] Shimano H, Yamada N, Katsuki M, et al.Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B[J]. J Clin Invest, 1992, 90(5):2084-2091. [34] Khan TA, Shah T, Prieto D, et al.Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals[J]. Int J Epidemiol, 2013, 42(2):475-492. [35] Plump AS, Smith JD, Hayek T, et al.Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells[J]. Cell, 1992, 71(2):343-353. [36] Piedrahita J, Zhang SH, Hagaman JR, et al.Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells[J]. Proc Natl Acad Sci USA, 1992, 89(10):4471-4475. [37] Moghadasian MH, McManus BM, Nguyen LB, et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans[J]. FASEB J, 2001, 15(14):2623-2630. [38] Hansson GK.Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16):1685-1695. [39] Hafezi-Moghadam A, Thomas KL, Wagner DD.ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage[J]. Am J Physiol Cell Physiol, 2007, 292(4): C1256-1262. [40] Levy-Lahad E, Bird TD.Genetic factors in Alzheimer’s disease: a review of recent advances[J]. Ann Neurol, 1996, 40(6):829-840. [41] Tseng YL, Kuwaki K, Dor FJ, et al.alpha1, 3-Galacto-syltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months[J]. Transplantation, 2005, 80(10):1493-1500. [42] Sun X, Sui H, Fisher JT, et al.Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis[J]. J Clin Invest, 2010, 120(9):3149-3160. [43] Ni W, Qiao J, Hu S, et al.Efficient gene knockout in goats using CRISPR/Cas9 system[J]. PLoS One, 2014, 9(9):e106718. [44] Wang Y, Fan N, Song J, et al.Generation of knockout rabbits using transcription activator-like effector nucleases[J]. Cell Regen (Lond), 2014, 3(1):3. [45] Santiago Y, Chan E, Liu PQ, et al.Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases[J]. Proc Natl Acad Sci U S A, 2008, 105(15):5809-5814. [46] Osiak A, Radecke F, Guhl E, et al.Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases[J]. PLoS One, 2011, 6(12): e28911. [47] Zakhartchenko V, Flisikowska T, Li S, et al.Cell-mediated transgenesis in rabbits: chimeric and nuclear transfer animals[J]. Biol Reprod, 2010, 84(2): 229-237. [48] Cade L, Reyon D, Hwang WY, et al.Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs[J]. Nucleic Acids Res, 2012, 40(16): 8001-8010. [49] Cong L, Ran FA, Cox D, et al.Multiplex genome engineering using CRISPR/Cas systems[J]. Science, 2013, 339(6121): 819-823. [50] Mali P, Yang L, Esvelt KM, et al.RNA-guided human genome engineering via Cas9[J]. Science, 2013, 339(6121):823-826. [51] Barrangou R.RNA-mediated programmable DNA cleavage[J]. Nat Biotechnol, 2012, 30(9):836-838. [52] Ma S, Chang J, Wang X, et al.CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori[J]. Sci Rep, 2014, 4:4489. [53] Zhou J, Shen B, Zhang W, et al.One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering[J]. Int J Biochem Cell Biol, 2014, 46:49-55. [54] Li W, Teng F, Li T, et al.Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems[J]. Nat Biotechnol, 2013, 31(8):684-686. [55] Chang N, Sun C, Gao L, et al.Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos[J]. Cell Res, 2013, 23(4):465-472. [56] Bassett AR, Tibbit C, Ponting CP, et al.Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system[J]. Cell Rep, 2013, 4(1):220-228. [57] Friedland AE, Tzur YB, Esvelt KM, et al.Heritable genome editing in C. elegans via a CRISPR-Cas9 system[J]. Nat Methods, 2013, 10(8):741-743. [58] Niu Y, Shen B, Cui Y, et al.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos[J]. Cell, 2014, 156(4):836-843. [59] Li X, Yang Y, Bu L, et al.Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing[J]. Cell Res, 2014, 24(4):501-504. [60] Yan Q, Zhang Q, Yang H, et al.Generation of multi-gene knockout rabbits using the Cas9/gRNA system[J]. Cell Regen (Lond), 2014, 3(1):12. |